RecruitingEarly Phase 1NCT07227883

Secretome Treatment for Facial Rejuvenation

Blinded, Randomized, Controlled, Trial to Evaluate the Efficacy and Safety of Autologous Hair Follicle Secretome for Facial Rejuvenation

Sponsor

Acorn Biolabs Inc.

Enrollment

24 participants

Start Date

Dec 15, 2025

Study Type

INTERVENTIONAL

Conditions

Stem Cell Facial Aging Rejuvenation Stem Cell Banking

Summary

Secretome treatment for facial rejuvenation

Eligibility

Min Age: 30 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Autologous Hair Follicle-Derived Secretome and Control Saline for people with facial aging, rejuvenation, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.